Association of SGLT2 inhibition with psychiatric disorders: A Mendelian randomization study
This study provides genetic evidence supporting that SGLT2 inhibitors increase the risk of obsessive-compulsive disorder, anxiety disorder, and bipolar affective disorder.
Authors
- Chen Li (ORCID: https://orcid.org/0000-0001-6994-1253)
- Le Liu (ORCID: https://orcid.org/0000-0002-6944-5417)
- Shuang Li (ORCID: https://orcid.org/0000-0003-4073-6461)
- Youshuo Liu (ORCID: https://orcid.org/0000-0003-4087-782X)
- Junkun Zhan
Institutions
- Central South University (CN)
- Institute of Aging (CA)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1278
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- National Natural Science Foundation of China